Adaptive Biotechnologies Corp (NASDAQ:ADPT)
| 8.82 Delayed Data As of Mar 31 |  +0.395 / +4.69%Today’s Change | 5.96 Today|||52-Week Range 15.19 | +15.38% Year-to-Date |
Latest ADPT News | Press Releases
| Philips (PHG) Drives Health Care Prospects With New Solutions Mar 28 / Zacks.com - Paid Partner Content | BridgeBio Pharma (BBIO) Surges 77% YTD: Here's Why Mar 22 / Zacks.com - Paid Partner Content |
| Is Fulgent Genetics (FLGT) Stock Outpacing Its Medical Peers This Year? Mar 27 / Zacks.com - Paid Partner Content | Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study Mar 21 / Zacks.com - Paid Partner Content |
| Sanofi's (SNY) Dupixent Meets Goal in Pivotal COPD Study Mar 23 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 8.42 |
| Today’s open | 8.56 |
| Day’s range | 8.56 - 8.93 |
| Volume | 33,019 |
| Average volume (3 months) | 948,104 |
| Market cap | $1.3B |
Data as of 4:00pm ET, 03/31/2023
Growth & Valuation
| Earnings growth (last year) | +4.88% |
| Earnings growth (this year) | +14.30% |
| Earnings growth (next 5 years) | +21.58% |
| Revenue growth (last year) | +20.06% |
| P/E ratio | NM |
| Price/Sales | 5.88 |
| Price/Book | 2.73 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Karo Healthcare AB | 0.00 | 0.00% |
| FGENFibroGen Inc | -0.06 | -0.32% |
| AVXLAnavex Life Sciences... | +0.28 | +3.37% |
| AMRNAmarin Corporation P... | -0.03 | -1.95% |
Data as of 4:00pm ET, 03/31/2023
Financials
| Next reporting date | May 3, 2023 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $185.3M |
| Annual profit (last year) | -$200.2M |
| Net profit margin | -108.03% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
